Sleep · Brain health technique
Moderate-risk sleep medications
Evidence grade: Weak
Short-acting “Z-drugs” (zolpidem, eszopiclone, zaleplon) that act on GABA-A receptors to promote sleep initiation, similar to benzodiazepines but with shorter duration.
- Practice
- Sleep
- Principle
- Restoration
- Tactic
- Medication And Supplements
- Evidence grade
- Weak
- Strength of evidence
- Low
How to practice Moderate-risk sleep medications
NN/A
The evidence behind Moderate-risk sleep medications
Z-drugs improve sleep latency by 10–20 minutes and total sleep by 30–45 minutes, but long-term efficacy and safety are limited. Risks include dependence, tolerance, next-day impairment, and rare complex sleep behaviors (e.g., sleep-driving). Mechanistically, they sedate rather than restore normal sleep architecture. Evidence mixed for sustained cognitive benefit and potential harm in older adults.
More Sleep techniques
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.